Dr. Adi Elkeles is an experienced executive who has a proven track record in leading biomedical entrepreneurship and innovation over two decades. He has managed the development of technologies from early preclinical research through commercialization and closed numerous strategic partnership agreements.
Prior to founding Trobix Bio, Adi served as vice-president for business development at Ramot, the technology transfer office of Tel Aviv University where he led business development, licensing and strategy for Life Sciences. He was Chief Technology Officer and Chief Business Development Officer at cancer diagnostic company Micromedic, where he led commercialization, in-licensing and out-licensing activities. At cancer diagnostic company Zetiq Technologies, serving as CEO, he led the company from preclinical research to commercialization. Prior to that, Adi held several managerial positions leading preclinical development programs for oncology, infectious and other diseases at BiolineRx, a technology incubator, and XTLbio.
Adi holds a PhD from Tel Aviv University, an MBA from the College of Management (Israel), and completed his post-doctoral fellowship at the Weizmann Institute of Science, Israel. Adi is an alumnus of the Paul Merage Life Science Executive Leadership Program of UC Irvine, California.